← Back to Search

Behavioral Intervention

Electronic Symptom Management for Advanced Cancer

N/A
Recruiting
Led By Kathryn Schmitz, PhD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of two years
Awards & highlights

Study Summary

This trial is testing whether an electronic symptom management system can help people with stage 3 and 4 cancer live longer, specifically those who live in rural areas.

Who is the study for?
This trial is for adults with advanced stage 3 or 4 cancer, living in certain rural areas, who are undergoing treatment (not just palliative care). They must have a life expectancy of at least 6 months, be able to use a phone for check-ins, and not be part of other supportive care studies.Check my eligibility
What is being tested?
Nurse AMIE is an electronic system designed to help manage symptoms in cancer patients. The study compares its effectiveness on survival rates against usual care without this technology among those living in rural settings.See study design
What are the potential side effects?
Since Nurse AMIE is a symptom management system rather than a drug, it doesn't have traditional side effects. However, there may be issues related to the usability or accessibility of the technology that could affect patient experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of two years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of two years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Survival
Secondary outcome measures
Change in Health-Related Quality of Life measured using the 36-Item Short Form Health Survey (SF-36)
Change in Physical Function measured using the Short Physical Performance Battery (SPPB)
Change in Symptoms measured using the Patient-Reported Outcomes Measurement Information System: The PROMIS ®-Preference (PROPr)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nurse AMIE Supportive Care InterventionExperimental Treatment1 Intervention
Participants in the intervention arm will receive the computer tablet with the Nurse AMIE program. Nurse AMIE will assess their symptoms daily and provide an intervention to help manage their symptoms.
Group II: Usual CareActive Control1 Intervention
Participants in the usual care arm will receive a book with some supportive care educational materials and recommendations.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nurse AMIE
2017
N/A
~10

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
494 Previous Clinical Trials
2,798,498 Total Patients Enrolled
University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,592 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,925,789 Total Patients Enrolled

Media Library

Cancer Research Study Groups: Nurse AMIE Supportive Care Intervention, Usual Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are participating in this clinical experiment?

"Affirmative, the clinicaltrials.gov portal reveals that this experiment is in search of participants. This research was posted on April 1st 2022 and has since been revised on October 6th 2022. 344 individuals are currently needed to be enrolled from 2 sites."

Answered by AI

Are any new participants being admitted for this experiment?

"Clinicaltrials.gov states that this medical trial is presently enrolling participants, with its initial posting dated April 1st 2022 and the latest update on October 6th 2022."

Answered by AI
~176 spots leftby Apr 2026